The biotech had tested the oral asset, dubbed VK2735, at doses ... In a Sunday poster presentation at the ObesityWeek conference in San Antonio ...
News
- Viking oral obesity med posts 6.8% weight loss for highest dose - Fierce Biotech
- Congruence Therapeutics Announces Blitz Talk Award and Poster Presentations on MC4R ...
Obesity Week will take place on November 3-6, 2024, in San Antonio, TX. ... Congruence is a computationally-driven biotechnology company building ...
- AstraZeneca Says Obesity Pill Well-Tolerated, Highly Competitive - Bloomberg News
AstraZeneca licensed the pill from Chinese biotech Eccogene last year, as it attempted ... San Antonio, Texas. There was a “dose dependent ...
- Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell ...
... biotech companies at its facilities in San Antonio, Texas. Its analytical services include development of a comprehensive range of analytical test ...
- VC funding update: Boston startups and tech firms raised $1.16 billion in October
San Antonio Inno · Seattle Inno · St. Louis Inno · Tampa Bay Inno · Triad Inno ... According to a Form D filing, Treeline Biosciences, a Watertown-based ...